|4Sep 15, 8:28 AM ET

Carson Lisa Cabott 4

4 · Phio Pharmaceuticals Corp. · Filed Sep 15, 2025

Insider Transaction Report

Form 4
Period: 2025-09-11
Carson Lisa Cabott
Chief Financial Officer
Transactions
  • Award

    Common Stock, $.0001 par value

    2025-09-11+47,00047,000 total
Footnotes (2)
  • [F1]Represents shares underlying a restricted stock unit, which shares will vest on the first annual anniversary of the grant.
  • [F2]Includes shares of common stock underlying unvested restricted stock units.

Documents

1 file
  • 4
    ownership.xmlPrimary